ifosfamide has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In three new approved indications (non Hodgkin's lymphoma, Hodgkin's lymphoma and acute lymphoblastic leukaemia) and in three previously existing indications (ovarian cancer, soft tissue sarcomas and osteogenic sarcomas), non comparative trials show that ifosfamide can induce tumour regression in patients who relapse after a first course of chemotherapy (sometimes containing cyclophosphamide)." | 3.70 | Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness. ( , 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
1 other study available for ifosfamide and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Child; Clinical Trials as Topic; Cycloph | 1998 |